These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32629758)

  • 1. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
    Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenging dicarbonyls with 5'-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance.
    Huang J; Tao H; Yancey PG; Leuthner Z; May-Zhang LS; Jung JY; Zhang Y; Ding L; Amarnath V; Liu D; Collins S; Davies SS; Linton MF
    Mol Metab; 2023 Jan; 67():101651. PubMed ID: 36481344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
    Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF
    Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
    Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
    J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.
    Zhu Y; Huang X; Zhang Y; Wang Y; Liu Y; Sun R; Xia M
    J Clin Endocrinol Metab; 2014 Feb; 99(2):561-9. PubMed ID: 24285687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus.
    Sanda GM; Toma L; Barbalata T; Moraru OE; Niculescu LS; Sima AV; Stancu CS
    Biofactors; 2022 Mar; 48(2):454-468. PubMed ID: 34741558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
    Shao B
    Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
    Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
    J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.
    Linton MF; Yancey PG; Tao H; Davies SS
    Circ Res; 2023 May; 132(11):1521-1545. PubMed ID: 37228232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
    Aggarwal G; May-Zhang LS; Yermalitsky V; Dikalov S; Voynov MA; Amarnath V; Kon V; Linton MF; Vickers KC; Davies SS
    J Biol Chem; 2021 Sep; 297(3):101019. PubMed ID: 34331945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.
    May-Zhang LS; Yermalitsky V; Melchior JT; Morris J; Tallman KA; Borja MS; Pleasent T; Amarnath V; Song W; Yancey PG; Davidson WS; Linton MF; Davies SS
    J Biol Chem; 2019 Dec; 294(50):19022-19033. PubMed ID: 31666337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.
    Rosenblat M; Vaya J; Shih D; Aviram M
    Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein.
    Sun H; Shen J; Liu T; Tan Y; Tian D; Luo T; Lai W; Dai M; Guo Z
    Atherosclerosis; 2014 Dec; 237(2):853-61. PubMed ID: 25463133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.